Members Login
Channels
Special Offers & Promotions
Caribou Biosciences and Integrated DNA Technologies (IDT) Announce Non-Exclusive License Agreement for CRISPR-Cas9 Reagents
publication date: Mar 30, 2016
|
author/source: Integrated DNA Technologies
Caribou Biosciences, Inc., a developer of CRISPR technologies for precision cell engineering, and Integrated DNA Technologies, Inc. (IDT), a producer of custom synthetic oligonucleotide-based technologies for genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou™s intellectual property.
The license is subject to a research use limited label.
"We are proud to partner with Integrated DNA Technologies, a prominent leader in the field of nucleic acid based technologies",
Media Partners